It’s time for a worldwide moratorium on editing human embryos

By Karen Loudon / April 2, 2019
by Alan Trounson Hear Alan Trounson discuss the issue Saturday 6 April at 12 noon on ABC Radio National’s The...
Read More

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

By Karen Loudon / April 2, 2019 UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells Fate Therapeutics, in collaboration with...
Read More

Tom’s Long Fight

By Karen Loudon / March 25, 2019
Tom Long's battle with Multiple Myeloma Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday...
Read More

From Bangladesh to Melbourne …… via Perth

By Karen Loudon / March 25, 2019
Ms Rasa Islam is Cartherics’ first full-time PhD student. She’s joining the team under a prestigious Cooperative Research Centre (CRC)...
Read More

Australia is handicapped in the delivery of cell therapies, says Alan Trounson

By Karen Loudon / March 21, 2019
THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer...
Read More

Safer cells for immunotherapy

By Karen Loudon / February 13, 2019
Cartherics Pty Ltd teams up with Canada's panCELLa Inc to bring the power of safe cell therapy to a greater...
Read More

Eradicate Cancer 2020 – Next frontiers in immunotherapy

By Karen Loudon / January 29, 2019
Melbourne Convention and Exhibition Centre, 25-27 March 2020 "Success Breeds Success" The field of immunotherapy against cancers is making unprecedented...
Read More


By Karen Loudon / January 21, 2019
Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and...
Read More

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories

By Karen Loudon / December 20, 2018 In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells...
Read More

‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)

By Karen Loudon / December 19, 2018
Sydney Morning Herald (By Esther Han) 19 December 2018 — 12:00am A revolutionary cancer therapy that supercharges a patient's...
Read More

Meet our newest recruit

By Karen Loudon / December 18, 2018
Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal. I’ve always had...
Read More

Come Hell Or High Water

By Karen Loudon / December 4, 2018
Cartherics Communications Adviser Leigh Dayton reveals the lengths Cartherics co-founder and immunologist Richard Boyd will go to for a good...
Read More

The Beautiful Cure’ Reveals The ‘Profound’ Power Of The Immune System

By Karen Loudon / November 29, 2018
An interview with UK immunologist Daniel Davis on national Public Radio's "Fresh Air" is a good discussion about his new...
Read More

Cartherics Corporate Adviser Dr Ian Nisbet talks about ‘what pisses him off’

By Karen Loudon / November 22, 2018
WHAT PISSES ME OFF When it comes to taking ideas to market, Corporate Advisor Ian Nisbet says America’s entrepreneurial ethos...
Read More